Hong Kong Stock Movement | Ascletis Pharma-B (01672.HK) rises over 6% as GLP-1 oral small molecule ASC30 initiates global Phase III clinical trials.

Zhihu Finance APP learned that Gilead Pharmaceuticals-B (01672.HK) rose over 6%. As of the time of this report, it increased by 5.94%, trading at HKD 9.535, with a transaction volume of HKD 13.7445 million.